Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinan Hongrui Chuangbo Pharmaceutical Technology Development is a specialized pharmaceutical research and development enterprise based in Jinan, China. The company focuses on the technology development, transfer, and technical consultation of chemical drugs, with a particular emphasis on high-end pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). Their core business involves providing custom synthesis services and optimizing manufacturing processes for generic medications across various therapeutic areas, including cardiovascular and metabolic diseases. By leveraging their expertise in organic synthesis, they support pharmaceutical manufacturers in achieving efficient and cost-effective production routes. The firm is recognized for its contributions to the local pharmaceutical technology landscape in the Shandong province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinan Hongrui Chuangbo Pharmaceutical Technology Development.